Novartis Share Price Borsa Italiana
Stocks
NOVN
CH0012005267
Pharmaceuticals
OTC Markets Traded
| Market Cap | 27TCr 23TCr 22TCr 20TCr 38TCr 25,30400Cr 38TCr 2,56900Cr 1LCr 12,45500Cr 1,00700Cr 99TCr 43,24700Cr | P/E 2026 * |
20.3x | P/E 2027 * | 17.4x |
|---|---|---|---|---|---|
| Enterprise Value | 30TCr 26TCr 24TCr 23TCr 43TCr 28,34800Cr 43TCr 2,87800Cr 1,11500Cr 13,95300Cr 1,12800Cr 1,10400Cr 48,45000Cr | EV / Sales 2026 * |
5.27x | EV / Sales 2027 * | 4.91x |
| Free-Float |
91.66% | Yield 2026 * |
3.05% | Yield 2027 * | 3.14% |
Last Transcript: Novartis
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 50 | 01/02/2018 | |
Mukul Mehta
DFI | Director of Finance/CFO | - | 16/03/2026 |
Shreeram Aradhye
CTO | Chief Tech/Sci/R&D Officer | 64 | 16/05/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Nancy Andrews
BRD | Director/Board Member | 68 | 01/01/2015 |
| Director/Board Member | 69 | 01/01/2016 | |
Ton Büchner
BRD | Director/Board Member | 61 | 01/01/2016 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -2.58% | - | - | 27TCr | |
| -1.21% | -3.04% | +44.03% | +142.51% | 98TCr | |
| -2.48% | -5.18% | +52.47% | +39.36% | 55TCr | |
| -2.14% | -4.94% | +16.83% | +58.18% | 38TCr | |
| +0.25% | -3.09% | +23.33% | +16.78% | 32TCr | |
| +0.61% | -1.69% | +27.35% | +14.22% | 27TCr | |
| +4.59% | +1.98% | -38.43% | -46.41% | 20TCr | |
| -1.19% | -4.95% | +16.68% | +48.70% | 18TCr | |
| -1.35% | -1.46% | +14.06% | +59.46% | 15TCr | |
| -2.74% | -3.82% | +5.17% | -35.19% | 14TCr | |
| Average | -0.57% | -3.08% | +17.95% | +33.07% | 35.31TCr | |
| Weighted average by Cap. | -0.88% | -3.72% | +28.80% | +61.80% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.7TCr 4.97TCr 4.6TCr 4.31TCr 8.08TCr 5,38000Cr 8.13TCr 55TCr 21TCr 2,64800Cr 21TCr 21TCr 9,19500Cr | 6.04TCr 5.27TCr 4.88TCr 4.57TCr 8.57TCr 5,70200Cr 8.62TCr 58TCr 22TCr 2,80600Cr 23TCr 22TCr 9,74500Cr |
| Net income | 1.41TCr 1.23TCr 1.14TCr 1.07TCr 2.01TCr 1,33500Cr 2.02TCr 14TCr 5.25TCr 66TCr 5.31TCr 5.2TCr 2,28200Cr | 1.57TCr 1.37TCr 1.27TCr 1.18TCr 2.22TCr 1,47900Cr 2.24TCr 15TCr 5.82TCr 73TCr 5.88TCr 5.76TCr 2,52700Cr |
| Net Debt | 3.23TCr 2.81TCr 2.61TCr 2.44TCr 4.57TCr 3,04400Cr 4.6TCr 31TCr 12TCr 1,49800Cr 12TCr 12TCr 5,20300Cr | 2.83TCr 2.47TCr 2.29TCr 2.14TCr 4.01TCr 2,67000Cr 4.04TCr 27TCr 11TCr 1,31400Cr 11TCr 10TCr 4,56400Cr |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
